Author | Naval Daver, MD | OncLive

Author | Naval Daver, MD

Articles

Dr. Daver on the Mechanism of Action of Magrolimab in AML/MDS

June 17, 2020

Video

Naval G. Daver, MD, discusses the mechanism of action of the investigational CD47-directed antibody magrolimab in acute myeloid leukemia and myelodysplastic syndrome.

Dr. Daver Discusses Single-Agent Immunotherapy in AML

December 19, 2017

Video

Naval Daver, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses single-agent immunotherapy in acute myeloid leukemia.

Dr. Daver on CAR T-Cell Therapy Approval in Pediatric ALL

November 16, 2017

Video

Naval Daver, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses the approval of a chimeric antigen receptor (CAR) T-cell therapy in pediatric acute lymphoblastic leukemia.

Dr. Daver on Immune Checkpoint Pathways in AML

December 28, 2016

Video

Naval Daver, MD, assistant professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses research evaluating different immune checkpoint pathways in patients with acute myeloid leukemia.

x